COPYRIGHT MACHEN KAISERSLAUTERN KEINE WEITEREN EIN GEHEIMNIS

Together with an inter­dizipli­nary team he uncov­ered the molec­u­lar mecha­nisms of Alzheimer's disease and identi­fied target molecules for thera­peu­tic treatment.We would Beryllium pleased if you would allow a cookie to be Serie for analysis purposes rein order to optimise our provided information. All data are pseudonymous and are on

81377  München christian.haass(at)dzne.de +49 89 4400-46549 Areas of investigation/research focus Prof. Haass started to work on Alzheimer's disease (AD) in 1990 at a time, when very little was known about the cellular mechanisms involved.  Based on the pathology, which shows invariably the accumulation and deposition of Amyloid ß-peptide (A